GlassScriptPhysician profile
David L Adler
NPI 1750386983
$49,757.76
in general payments reported to CMS, 2019-2025
30 companies · $509 in 2025
The $509 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,283 · 2020: $165 · 2021: $24K · 2022: $6,953 · 2023: $4,434 · 2024: $12K · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,500 · Consulting Fee: $3,600 · Honoraria: $3,495 · Travel and Lodging: $2,231 · Food and Beverage: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,500.00 |
| Consulting Fee | $3,600.00 |
| Honoraria | $3,495.00 |
| Travel and Lodging | $2,231.39 |
| Food and Beverage | $1,484.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $34,263.76 | 2021-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Shield Therapeutics INC | $12,544.68 | 2023-2025 | Accrufer |
| Hologic Sales and Service, LLC | $1,250.41 | 2019-2025 | Aptima, Thinprep 2000 Processor, Fluent Fluid Management System |
| Mayne Pharma Commercial LLC | $282.64 | 2021-2025 | |
| Medline Industries LP | $135.85 | 2022 | |
| Meditrina | $111.23 | 2021 | |
| Channel Medsystems, INC. | $97.22 | 2025 | |
| Abbvie INC. | $94.81 | 2020-2022 | |
| Organon LLC | $85.92 | 2021-2024 | Nexplanon |
| Exeltis, USA INC. | $80.71 | 2019-2024 | Slynd |
| Allergan, INC. | $74.30 | 2019-2020 | |
| Aspira Women'S Health INC | $74.12 | 2023 | Ova1 |
| Therapeuticsmd, INC. | $61.76 | 2019 | |
| Pfizer INC. | $54.56 | 2023-2024 | |
| Myovant Sciences INC. | $53.36 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $51.82 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $48.85 | 2023 | Myfembree |
| Biogen, INC. | $44.95 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $44.93 | 2024-2025 | Cologuard Collection Kit |
| Merz North America, INC. | $44.91 | 2020-2021 | |
| Intra-Sana Laboratories | $43.06 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Cook Medical LLC | $40.02 | 2020 | |
| Avion Pharmaceuticals | $28.14 | 2019-2023 | Balcoltra |
| Virtus Pharmaceuticals LLC | $26.90 | 2021 | |
| Lilly USA, LLC | $23.20 | 2024 | Zepbound |
| Evofem Biosciences, INC. | $22.30 | 2021 | |
| Cepheid | $21.46 | 2025 | Genexpert |
| Novo Nordisk INC | $20.97 | 2023 | Saxenda, Wegovy |
| Millicent US INC | $16.28 | 2025 | Femlyv |
| Agile Therapeutics, INC. | $14.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Adler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.